Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families

• Main Authors: Eric L. Simpson (Author), Amy S. Paller (Author), Mark Boguniewicz (Author), Lawrence F. Eichenfield (Author), Steven R. Feldman (Author), Jonathan I. Silverberg (Author), Sarah L. Chamlin (Author), Lee T. Zane (Author)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2018-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Introduction The impact of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD), on quality of life (QoL) was assessed in two identically designed phase 3 studies (AD-301: NCT02118766; AD-302: NCT02118792, both at ht...